Drug intelligence / Profile preview

Modified Simiao Yong'an Soup

Development stage
Preclinical
Lead developer
Xiyuan Hospital
Administration
Oral
01

Overview

Modified Simiao Yong'an Soup is a traditional Chinese medicine (TCM) formula derived from the classic Simiao Yong'an Decoction. It is currently under investigation for the treatment of non-infectious uveitis. The base formula, Simiao Yong'an Decoction, is recognized for its multi-targeted therapeutic actions, including anti-inflammatory, anti-apoptotic, and immunomodulatory effects. It has been shown to modulate various signaling pathways involved in inflammation, cell survival, and angiogenesis. This herbal preparation is typically administered orally.

Other names
Modified Simiao Yong'an Soup Recipe GranulesSi-Miao-Yong-An DecoctionSMYAD
02

Targets

TLR4 (Toll-like receptor 4)VEGFA (Vascular endothelial growth factor A)MAPK3 (Mitogen-activated protein kinase 1)PDGFRB (Platelet-derived growth factor receptor beta)TGFB1 (Transforming growth factor Beta-1 proprotein)NF-κBCXCL2 (C-X-C motif chemokine ligand 2)ICAM1 (Intercellular Adhesion Molecule 1)IL8 (C-X-C Motif Chemokine Ligand 8)VEGFR2 (Vascular endothelial growth factor receptor 2)AGER (RAGE)AKT (RAC-alpha serine/threonine-protein kinase)JAK1 (Janus kinase 1)HDAC1 (Histone Deacetylase 1)HIF1A (Hypoxia-inducible factor 1-alpha)CCND1 (Cyclin D1)IL-6 (Interleukin 6)CCL2 (C-C motif chemokine 2)CXCL1 (C-X-C motif chemokine ligand 1)FGF2PI3K (Phosphoinositide-3-kinase regulatory subunit 6)VCAM1 (Vascular cell adhesion molecule 1)CDK4 (Cyclin-dependent kinase 4)PDE5 (Phosphodiesterase 5A)PPARG (Peroxisome proliferator-activated receptor gamma)MMP9 (Matrix metalloproteinase-9)IL1B (Interleukin-1 beta)TNFA (Tumor necrosis factor alpha (soluble))NOX4 (NADPH oxidase 4)ATM (Ataxia telangiectasia mutated protein)

Beyond the preview

Go deeper on Modified Simiao Yong'an Soup.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Modified Simiao Yong'an Soup.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call